September 2, 2014

FDA Approves Neurotoxic Flu Drug For Infants Less Than One

pin it button FDA Approves Neurotoxic Flu Drug For Infants Less Than One

pharma influenza FDA Approves Neurotoxic Flu Drug For Infants Less Than One

by Sayer Ji
GreenMedInfo.com

Whereas the flu is self-limiting, the FDA’s capacity for bad decisions is not…

The recent decision by the FDA to approve the use of the antiviral drug Tamiflu for treating influenza in infants as young as two weeks old, belies an underlying trajectory within our regulatory agencies towards sheer insanity.

Tamiflu, known generically as oseltamivir, has already drawn international concern over its link with suicide deaths in children given the drug after its approval in 1999. In fact, in 2004, the Japanese pharmaceutical company Chugai added “abnormal behavior” as a possible side effect inside Tamiflu’s package.  The FDA also acknowledged in its April, 2012 “Pediatric Postmarket Adverse Event Review” of Tamiflu that “abnormal behavior, delirium, including symptoms such as hallucinations, agitation, anxiety, altered level of consciousness, confusion, nightmares, delusions” are possible side effects.[i]

Recent animal research on Tamiflu has found that the infant brain absorbs the drug more readily than the adult brain,[ii]  [iii]lending a possible explanation for why neuropsychiatric side effects have been observed disproportionately in younger patients.

The very mechanism of Tamiflu’s anti-influenza action may hold the key to its well-known neurotoxicity. Known as a neuromindase inhibitor, the drug inhibits the key enzyme within the flu virus that enables it to enter through the membrane of the host cell.  So fundamental is this enzyme that viruses are named after this antigenic characteristic. For instance,  the “N” in H1N1 flu virus is named for type 1 viral neuromindase.

Mammals, however, also have neurimindase enzymes, known as ‘sialidase homologs,’ with four variations identified within the human genome so far; NEU1,NEU2,NEU3 and NUE4.  These enzymes are important for neurological health. For example, the enzyme encoded by NEU3, is indispensable for the modulation of the ganglioside content of the lipid bilayer, which is found predominantly in the nervous system and constitutes 6% of all phospholipids in the brain.

It is therefore likely that neurimindase-targeted drugs like Tamiflu are simply not selective enough to inhibit only the enzymes associated with influenza viral infectivity. They likely also cross-react with those off-target neurimindase enzymes associated with proper neurological function within the host. This “cross reactivity” with self-structures may also explain why the offspring of pregnant women given Tamiflu have significantly elevated risk of birth defects (10.6%) relative to background rates (2-3%), according to a 2009 safety review by the European Medicines Agency.

Beyond the recognition of Tamiflu’s intrinsic toxicity, there are two additional problems with the use Tamiflu in infants:

  1. Infants do not yet have a sufficiently developed blood-brain barrier capable of keeping the chemical out of their rapidly developing brains
  2. Their detoxification systems are not sufficiently developed to remove the chemical rapidly enough to prevent harm

The FDA’s decision to include infants under one as treatable with Tamiflu is all the more disturbing when you consider that a 2010 study published in The Pediatric Infectious Disease Journal found that of 157 evaluable infants (mean age 6.3 months) treated for influenza with Tamiflu, complications due to the medication were found in the majority (54%) of the treated group.

According to the study

Complications were recorded in 84 patients (54%), the most serious of which were meningitis in 1 infant (1%), pneumonia in 9 (6%), and otitis media in 2 (1%).

Are meningitis, pneumonia and otitis media (ear infection) acceptable risks for treating influenza? Apparently for the FDA, it is.

How about death? Is that an acceptable risk of Tamiflu treatment for flu, a self-limiting disease?

In 2011, the International Journal of Vaccine Risk and Safety in Medicine published an article titled, “Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza,” described 119 reports of Tamiflu-induced death. According to the study:  “of 119 deaths after Tamiflu was prescribed, 38 deteriorated within 12 hours (28 within 6 hours).”

The study concluded:

These data suggest Tamiflu use could induce sudden deterioration leading to death especially within 12 hours of prescription. These findings are consistent with sudden deaths observed in a series of animal toxicity studies, several reported case series and the results of prospective cohort studies. From “the precautionary principle” the potential harm of Tamiflu should be taken into account and further detailed studies should be conducted.

So, how did the FDA justify its decision to consider Tamiflu safe in infants under one year? Did it use controlled, randomized, placebo-controlled trials to ascertain safety?  Of course not. Testing drugs on infants is unethical, and no parent in their right mind would enroll their newborn in such a trial. Lacking definitive evidence of safety, the FDA’s expanded approval in children younger than one year was based on extrapolation of data from previous results in adults and older children.[iv] This, of course, is inappropriate as it denies the aforementioned differences in the susceptibility to drug toxicity and neurotoxicity between infants and older individuals.  It also avoids proper consideration of the studies in the biomedical literature indicating its potential for severe, if not life-threatening toxicity to infants, children and adults alike.

Another concern, not addressed in the FDA announcement, is that as of Dec. 15th, 2010, the World Health Organization has acknowledged that, based on over 300 tested worldwide samples of the 2009 pandemic H1N1 flu, resistance to Tamiflu is growing.[v]  Therefore, treating an infant with Tamiflu-resistant influenza would not only do nothing to combat the infection, but would poison that child and further disable their natural immune response.

The clear winner in the FDA’s decision will be the bottom line of Roche, the manufacturer of this patented chemical.  How much longer can the FDA continue to expect those subject to its regulatory decisions to maintain the illusion that it is interested in the public welfare?

We must remember that infants do not get sick from the flu as a result of Tamiflu deficiency, or flu vaccine deficiency for that matter.  They do get sick from the immune-disrupting effects of synthetic chemicals completely foreign to human physiology (such as Tamiflu), and lack of vital hormone modulating compounds that result from adequate sunlight exposure (vitamin D3), and good nutrition.

For additional information on this topic view our research on natural anti-influenza agents.

Read the full article here: http://www.greenmedinfo.com/blog/fda-approves-neurotoxic-flu-drug-infants-less-one

Flu and Flu Vaccines:
What’s Coming Through That Needle – DVD

flu and flu vaccines whats coming through that needle DVD by dr tenpenny FDA Approves Neurotoxic Flu Drug For Infants Less Than One

More Info
FREE Shipping Available!


0 commentsback to post

Other articlesgo to homepage

Former Staff Lead on Original Congressional Investigation Looking at Vaccine Injuries Speaks Out on CDC Fraud

Former Staff Lead on Original Congressional Investigation Looking at Vaccine Injuries Speaks Out on CDC Fraud

Pin It

Beth Clay is a unique contributor to the CDC whistleblower story. Clay was the staff lead on the original House Oversight Committee’s investigation looking into concerns about vaccine injuries in 1999. Working in Congress, she had a genuine desire to find the truth and find solutions regarding the rapidly increasing autism rates. What she found during her time in Congress, however, shocked her. So the recent revelations of Dr. Thompson, the CDC whistleblower, are not really “news” to her. Sadly, a government agency withholding information about a link between vaccines and autism is representative of the kind of fraud she too observed during her years in Congress.

CDC Director of Immunization Safety Admits Bias and Withholding Data Linking Vaccines to Autism

CDC Director of Immunization Safety Admits Bias and Withholding Data Linking Vaccines to Autism

Pin It

In what is quickly becoming one of the largest news stories in our lifetime, things are just getting worse for the CDC and their cover-up of data linking vaccines to autism.

Investigative journalist Sharyl Attkisson has posted a recorded phone call she just had with Dr. Frank DeStefano, the CDC Director of Immunization Safety. Dr. DeStefano was a co-author with CDC whistleblower Dr. William Thompson on a 2004 study that originally was put forward as research showing there was no link between vaccines and autism. Dr. Thompson has come forward and revealed that data was withheld from the public that showed an increased risk of autism in certain populations, specifically African American boys. The CDC has already made a public announcement admitting that they did withhold some data.

Dr. DeStefano has publicly stated that while he will reveal the data again, but that he is standing by the original study. A new audio recording of a conversation he just had with independent investigative reporter Sharyl Attkisson has just been posted on the Internet.

In this interview, Dr. DeStefano, who is not a whistle-blower, has come out with his own confession of bias and way of interpreting data so that it does not have to be shared with the public if it is not favorable with what they want to communicate regarding vaccines.

Dr. DeSefano and the CDC is being forced to answer questions like this (which unfortunately the mainstream media as of yet are NOT asking) because his co-author on the study, Dr. William Thompson, has hired one of the top whistleblower attorney’s in the nation so that he can come forward and reveal all the data the CDC has been hiding in regards to vaccines and autism.

60+ Natural ALS Cures the “Ice Washing” Campaign Isn’t Funding!

60+ Natural ALS Cures the “Ice Washing” Campaign Isn’t Funding!

Pin It

In a previous article we published on where funds donated to the ALS Association are being spent, we showed that a small percentage was actually spent on research, and even then only on pharmaceutical products. This has been our most popular story of the year so far.

Sayer Ji brings us a great review of over 60 natural cures that have published research on helping ALS. He also shows how some of the corporate sponsors of the ALS Association are pharmaceutical companies producing drugs that are linked to the cause of ALS!

MSM Marginalizes CDC Whistleblower Story on Vaccine-Autism Coverup

MSM Marginalizes CDC Whistleblower Story on Vaccine-Autism Coverup

Pin It

CNN was the first mainstream media (MSM) outlet to publish a story on the CDC whistleblower story linking vaccines to autism. Predictably, CNN marginalized this story on their website, and then posted a video from their TV network which said nothing about the CDC whistleblower Dr. William Thompson, but simply reiterated the MSM’s belief that all vaccines are safe and do not cause autism. They have posted a video that incorrectly represents facts regarding infant mortality and current whooping cough outbreaks that are occurring among fully vaccinated populations.

How can we trust anything CNN says on the vaccine issue if they misrepresent such basic facts regarding vaccines that are easily verified by 3rd party sources?

This story regarding the CDC cover-up has become too big for the MSM to ignore. They have to address it, but predictably they will continue to cover the story from their own belief system that the vaccine-autism debate is over, and that only one side of the debate should be heard. For those reporters that would dare to cover both sides of the debate, they will soon be without a career in MSM. So perhaps the American public needs to wake up and acknowledge this fact, and research the issue for themselves. A current senior scientist working for the CDC who has regrets over his participation in covering up data linking vaccines to autism is something worth taking some time to research.

CDC Whistleblower: Mercury in Vaccines Given to Pregnant Women Linked to Autism

CDC Whistleblower: Mercury in Vaccines Given to Pregnant Women Linked to Autism

Pin It

Today, the Autism Media Channel released a short video where CDC whistle-blower Dr. William Thompson states, in a phone call to Dr. Brian Hooker, that injecting mercury into pregnant women creates a “clear and present danger” to the unborn child. Thimerosal, a form of mercury used as a preservative in vaccines, was removed from most childhood vaccines a few years ago, but is still in the annual flu shot, which is recommended for pregnant women.

Dr. Thompson, in the video below, insists that this mercury in vaccines causes “tics” in children, and these tics are 4 times more prevalent in kids with autism. “Tics” are defined on the CDC website as: “Tics are sudden twitches, movements, or sounds that people do repeatedly. People who have tics cannot stop their body from doing these things. For example, a person with a motor tic might keep blinking over and over again. Or, a person with a vocal tic might make a grunting sound unwillingly.”

Watch the short 1 minute video.

read more


Get the news right in your inbox!